You are here: Industry Insights > COVID-19

News List

FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19 americanpharmaceuticalreview
April 09, 2020
The U.S. Food and Drug Administration (FDA) continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19.
UK and Europe tackle false COVID-19 medicinal products europeanpharmaceuticalreview
April 09, 2020
The MHRA and Council of Europe have both announced measures to prevent the spread of falsified or unlicensed COVID-19 medical products.
Gilead aims to produce one million remdesivir treatment courses by 2021 europeanpharmaceuticalreview
April 09, 2020
A letter from the CEO of Gilead reveals how the company plans to scale up production of remdesivir in light of the COVID-19 pandemic.
EU authorities agree new measures to support the pharma supply chain during COVID-19 pandemic europeanpharmaceuticalreview
April 09, 2020
The European Medicines Agency (EMA) and other authorities have created a new shortage reporting system and are looking into how regulations can be applied more flexibly during the COVID-19 pandemic.
Indian Immunologicals, Griffith University to develop Covid-19 vaccine pharmaceutical-technology
April 09, 2020
Vaccine manufacturer Indian Immunologicals and Griffith University in Australia have partnered to develop a potential vaccine candidate against Covid-19.
University of Bristol, Imophoron to test Covid-19 vaccine candidates pharmaceutical-technology
April 09, 2020
The University of Bristol and spin-out firm Imophoron are set to assess Covid-19 vaccine candidates in-vivo in a pre-clinical programme.
FDA authorises Emory University to trial antiviral for Covid-19 pharmaceutical-technology
April 09, 2020
Emory University subsidiary DRIVE has received the US Food and Drug Administration (FDA) approval for its investigational new drug application of antiviral compound EIDD-2801 to treat Covid-19.
Kedrion Developing Plasma Therapy for COVID-19 contractpharma
April 09, 2020
Kedrion Biopharma, an Italian biotech company, has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients.
Recipharm’s Erdosteine to be Tested for COVID-19 Treatment contractpharma
April 09, 2020
Trial in Italy evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2.
Roche Accelerates Phase III Actemra Trial in COVID-19 contractpharma
April 09, 2020
Receives $25 million in support from BARDA to evaluate safety and efficacy in severe COVID-19 pneumonia.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page